Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026)

Accuray's (ARAY) quarterly Liabilities and Shareholders Equity came in at $447.6 million in Q1 2026, up 137.41% year-on-year from $188.5 million in Q1 2025, and up 139.68% quarter-over-quarter from $186.7 million in Q4 2025.

Accuray (ARAY) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Accuray's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $447.6 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 137.41% year-over-year to $447.6 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 101.74% increase from a year earlier, with the FY2025 full-year figure at $470.2 million, up 229.7% from the prior year.
  • Liabilities and Shareholders Equity grew to $447.6 million in Q1 2026 per ARAY's latest filing, from $186.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $470.2 million in Q2 2025 and bottomed at $90.7 million in Q2 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $121.3 million (2023), against an average of $168.8 million.
  • Across the five-year window, Liabilities and Shareholders Equity dropped 1.31% in 2023 and soared 229.7% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $105.4 million in 2022, then advanced by 15.12% to $121.3 million in 2023, then soared by 31.08% to $159.0 million in 2024, then gained by 17.44% to $186.7 million in 2025, then surged by 139.68% to $447.6 million in 2026.
  • Per Business Quant, the three latest ARAY Liabilities and Shareholders Equity figures stand at $447.6 million (Q1 2026), $186.7 million (Q4 2025), and $197.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Accuray 29,832.96 -38.50 Mn 25.29 Mn 447.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 447.60 Mn
Dec 31, 2025 186.75 Mn
Sep 30, 2025 197.12 Mn
Jun 30, 2025 470.24 Mn
Mar 31, 2025 188.54 Mn
Dec 31, 2024 159.01 Mn
Sep 30, 2024 155.06 Mn
Jun 30, 2024 142.63 Mn
Mar 31, 2024 114.93 Mn
Dec 31, 2023 121.31 Mn
Sep 30, 2023 108.08 Mn
Jun 30, 2023 90.74 Mn
Mar 31, 2023 104.17 Mn
Dec 31, 2022 105.37 Mn
Sep 30, 2022 92.18 Mn
Jun 30, 2022 91.94 Mn
Mar 31, 2022 93.48 Mn
Dec 31, 2021 84.46 Mn
Sep 30, 2021 81.93 Mn
Jun 30, 2021 54.52 Mn